Compound 12 afforded a critical anticancer activity against mutated FLT-ITD- MV4-11 and MOLM-13 acute myeloid leukemia cells with IC50 values of 5.9 and 5.5 nM, respectively. Here, FLT1 is linked to acute myeloid leukemia.